Invacare reports sales decrease
By HME News Staff
Updated Thu August 6, 2020
ELYRIA, Ohio - Invacare reported a net sales decrease of 16.8% to $196.3 million for the second quarter of 2020. Adjusted EBITDA improved by $3.3 million to $6.6 million. Operating loss improved by $2.3 million, or over 50%, to a loss of $2.2 million due to reduced SG&A expenses. “We achieved higher year-over-year adjusted EBITDA for the 11th consecutive quarter and have established a strong track record of continued improvement, despite a pandemic which reduced constant currency net sales by almost 13%,” said Matt Monaghan, chairman, president and CEO. “This accomplishment is a testament to our prior transformation initiatives, which have positioned Invacare to regain market leadership and continue to drive improved profitability.”
Comments